CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Alpha Tau Medical Treats First Immunocompromised Patient in Alpha DaRT Study

Trial StartAlpha DaRTPositive
AI Analysis

Summary

Alpha Tau Medical has enrolled the first immunocompromised patient in the Alpha DaRT study, representing a routine clinical trial milestone.

Clinical Trial Data

Importance:3/10
Sentiment:
0.50
clinical trialimmunocompromised patientspatient enrollment
Related Companies

Read the original article

Published by yahoo_finance on July 15, 2026 1:48 PM

Read Original